---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-073904"
form_type: "8-K"
ticker: "NTLA"
cik: "0001652130"
company_name: "Intellia Therapeutics, Inc."
filed_at: "2025-04-07T23:59:59+00:00"
generated_at: "2026-05-23T19:45:51.339182+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Intellia amends bylaws to adopt majority voting for uncontested director elections

## Summary
- Majority vote standard adopted for uncontested director elections; plurality retained for contested elections.
- Amended bylaws include proxy solicitation procedures consistent with SEC Rule 14a-19.
- Changes effective April 3, 2025; Board approved on recommendation of governance committee.
- Other clarifying and procedural amendments also made to the bylaws.

## SEC filing metadata
- accession: 0001193125-25-073904
- form_type: 8-K
- ticker: NTLA
- cik: 0001652130
- company_name: Intellia Therapeutics, Inc.
- filed_at: 2025-04-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/0001193125-25-073904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652130/000119312525073904/d901196d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-073904
- JSON: https://secwatch.observer/filing/0001193125-25-073904.json
- Plain text: https://secwatch.observer/filing/0001193125-25-073904.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.